Company in the news

Trendlines expects proceeds of $8 mil if sale of portfolio company is completed

Non-IFRS value of the portfolio at the end of June 2023 was US$152.8 million

SGX Research Series: 10 in 10

Trendlines: Refining narratives for investors

Trendlines promotes responsible and ethical operations among all its portfolio companies.

SGX Research Series: 10 in 10

The Trendlines Group – from seed to market

"We believe that our company is undervalued by the market."

Broker's Calls

NRA Capital says Trendlines is worth more than meets the eye

SINGAPORE (Nov 27): NRA Capital has found 11 “hidden gems” within Trendlines’ portfolio and derived a higher valuation of US$139 million ($187 million) or 22.5 cents per share.


Trendlines 2Q turns profitable compared to a year ago

SINGAPORE (Aug 7): Trendlines, the investor, incubator and developer of early-stage, high-medical and agricultural technology companies in Israel, has reported 2Q earnings of US$2.4 million compared to a loss of US$4.6 million a year ago.


Trendlines’ FY16 losses double to $9.4 mil

SINGAPORE (Feb 22): The Trendlines Group, an Israeli-based company focused on developing technology-based companies in the medical and agricultural fields, posted full-year loss of US$6.6 million ($9.4 million), double from its loss of US$3.3 million decl

Stocks To Watch

Ascendas India Trust, Fragrance, Cordlife, Jumbo, Trendlines

SINGAPORE (Feb 1): Here are some stocks that could move the market this Wednesday morning.

Stocks To Watch

SPH, GKE, CNMC, Hwa Hong, Trendlines, Dasin

SINGAPORE (Jan 16): Here are some stocks that could move the market this Monday morning:

B.Braun acquires 20.74% stake in Trendlines Medical Singapore

SINGAPORE (Dec 21): Trendlines Group has entered an agreement with B. Braun, the German medical device company, for the latter to become a 20.74% minority shareholder in the group’s wholly-owned subsidiary, Trendlines Medical Singapore.